 | • レポートコード：GIR-2104Z11073 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、肺炎球菌多価ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。肺炎球菌多価ワクチンの種類別市場規模（プレベナー13、肺炎球菌23）、用途別市場規模（18歳以下、19〜64歳、65歳以上）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・肺炎球菌多価ワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Merck & Co.、Pfizer ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：プレベナー13、肺炎球菌23 ・用途別分析2016年-2026年：18歳以下、19〜64歳、65歳以上 ・肺炎球菌多価ワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・肺炎球菌多価ワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・肺炎球菌多価ワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・肺炎球菌多価ワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・肺炎球菌多価ワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Pneumococcal Vaccine Polyvalent market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Pneumococcal Vaccine Polyvalent size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Pneumococcal Vaccine Polyvalent market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Pneumococcal Vaccine Polyvalent market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Prevnar 13
Pneumovax23
Market segment by Application can be divided into
18 Years and Younger
19 To 64 Years Old
65 Years and Older
The key market players for global Pneumococcal Vaccine Polyvalent market are listed below:
Merck & Co.
Pfizer
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Pneumococcal Vaccine Polyvalent Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pneumococcal Vaccine Polyvalent Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Prevnar 13
1.2.3 Pneumovax23
1.3 Market Analysis by Application
1.3.1 Overview: Global Pneumococcal Vaccine Polyvalent Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 18 Years and Younger
1.3.3 19 To 64 Years Old
1.3.4 65 Years and Older
1.4 Global Pneumococcal Vaccine Polyvalent Market Size & Forecast
1.4.1 Global Pneumococcal Vaccine Polyvalent Sales in Value (2016-2026))
1.4.2 Global Pneumococcal Vaccine Polyvalent Sales in Volume (2016-2026)
1.4.3 Global Pneumococcal Vaccine Polyvalent Price by Type (2016-2026) & (USD/Unit)
1.5 Global Pneumococcal Vaccine Polyvalent Production Capacity Analysis
1.5.1 Global Pneumococcal Vaccine Polyvalent Total Production Capacity (2016-2026)
1.5.2 Global Pneumococcal Vaccine Polyvalent Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pneumococcal Vaccine Polyvalent Market Drivers
1.6.2 Pneumococcal Vaccine Polyvalent Market Restraints
1.6.3 Pneumococcal Vaccine Polyvalent Trends Analysis
2 Manufacturers Profiles
2.1 Merck & Co.
2.1.1 Merck & Co. Details
2.1.2 Merck & Co. Major Business
2.1.3 Merck & Co. Pneumococcal Vaccine Polyvalent Product and Services
2.1.4 Merck & Co. Pneumococcal Vaccine Polyvalent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Pneumococcal Vaccine Polyvalent Product and Services
2.2.4 Pfizer Pneumococcal Vaccine Polyvalent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Pneumococcal Vaccine Polyvalent Sales by Manufacturer
3.1 Global Pneumococcal Vaccine Polyvalent Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Pneumococcal Vaccine Polyvalent Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Pneumococcal Vaccine Polyvalent
3.4 Market Concentration Rate
3.4.1 Top 3 Pneumococcal Vaccine Polyvalent Manufacturer Market Share
3.4.2 Top 6 Pneumococcal Vaccine Polyvalent Manufacturer Market Share
3.5 Global Pneumococcal Vaccine Polyvalent Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Pneumococcal Vaccine Polyvalent Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pneumococcal Vaccine Polyvalent Market Size by Region
4.1.1 Global Pneumococcal Vaccine Polyvalent Sales in Volume by Region (2016-2026)
4.1.2 Global Pneumococcal Vaccine Polyvalent Revenue by Region (2016-2026)
4.2 North America Pneumococcal Vaccine Polyvalent Revenue (2016-2026)
4.3 Europe Pneumococcal Vaccine Polyvalent Revenue (2016-2026)
4.4 Asia-Pacific Pneumococcal Vaccine Polyvalent Revenue (2016-2026)
4.5 South America Pneumococcal Vaccine Polyvalent Revenue (2016-2026)
4.6 Middle East and Africa Pneumococcal Vaccine Polyvalent Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Pneumococcal Vaccine Polyvalent Sales in Volume by Type (2016-2026)
5.2 Global Pneumococcal Vaccine Polyvalent Revenue by Type (2016-2026)
5.3 Global Pneumococcal Vaccine Polyvalent Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Pneumococcal Vaccine Polyvalent Sales in Volume by Application (2016-2026)
6.2 Global Pneumococcal Vaccine Polyvalent Revenue by Application (2016-2026)
6.3 Global Pneumococcal Vaccine Polyvalent Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Pneumococcal Vaccine Polyvalent Sales by Type (2016-2026)
7.2 North America Pneumococcal Vaccine Polyvalent Sales by Application (2016-2026)
7.3 North America Pneumococcal Vaccine Polyvalent Market Size by Country
7.3.1 North America Pneumococcal Vaccine Polyvalent Sales in Volume by Country (2016-2026)
7.3.2 North America Pneumococcal Vaccine Polyvalent Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Pneumococcal Vaccine Polyvalent Sales by Type (2016-2026)
8.2 Europe Pneumococcal Vaccine Polyvalent Sales by Application (2016-2026)
8.3 Europe Pneumococcal Vaccine Polyvalent Market Size by Country
8.3.1 Europe Pneumococcal Vaccine Polyvalent Sales in Volume by Country (2016-2026)
8.3.2 Europe Pneumococcal Vaccine Polyvalent Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Pneumococcal Vaccine Polyvalent Sales by Type (2016-2026)
9.2 Asia-Pacific Pneumococcal Vaccine Polyvalent Sales by Application (2016-2026)
9.3 Asia-Pacific Pneumococcal Vaccine Polyvalent Market Size by Region
9.3.1 Asia-Pacific Pneumococcal Vaccine Polyvalent Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Pneumococcal Vaccine Polyvalent Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Pneumococcal Vaccine Polyvalent Sales by Type (2016-2026)
10.2 South America Pneumococcal Vaccine Polyvalent Sales by Application (2016-2026)
10.3 South America Pneumococcal Vaccine Polyvalent Market Size by Country
10.3.1 South America Pneumococcal Vaccine Polyvalent Sales in Volume by Country (2016-2026)
10.3.2 South America Pneumococcal Vaccine Polyvalent Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pneumococcal Vaccine Polyvalent Sales by Type (2016-2026)
11.2 Middle East & Africa Pneumococcal Vaccine Polyvalent Sales by Application (2016-2026)
11.3 Middle East & Africa Pneumococcal Vaccine Polyvalent Market Size by Country
11.3.1 Middle East & Africa Pneumococcal Vaccine Polyvalent Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Pneumococcal Vaccine Polyvalent Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Pneumococcal Vaccine Polyvalent Typical Distributors
12.3 Pneumococcal Vaccine Polyvalent Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Pneumococcal Vaccine Polyvalent Revenue by Type, (USD Million), 2021-2026
Table 2. Global Pneumococcal Vaccine Polyvalent Revenue by Application, (USD Million), 2021-2026
Table 3. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 4. Merck & Co. Major Business
Table 5. Merck & Co. Pneumococcal Vaccine Polyvalent Product and Services
Table 6. Merck & Co. Pneumococcal Vaccine Polyvalent Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Pneumococcal Vaccine Polyvalent Product and Services
Table 10. Pfizer Pneumococcal Vaccine Polyvalent Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Global Pneumococcal Vaccine Polyvalent Sales by Manufacturer (2019-2021e) & (K Units)
Table 12. Global Pneumococcal Vaccine Polyvalent Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 13. Market Position of Manufacturers in Pneumococcal Vaccine Polyvalent, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 14. Global Pneumococcal Vaccine Polyvalent Production Capacity by Company, (K Units): 2020 VS 2021
Table 15. Head Office and Pneumococcal Vaccine Polyvalent Production Site of Key Manufacturer
Table 16. Global Pneumococcal Vaccine Polyvalent Sales by Region (2016-2021e) & (K Units)
Table 17. Global Pneumococcal Vaccine Polyvalent Sales by Region (2021-2026) & (K Units)
Table 18. Global Pneumococcal Vaccine Polyvalent Revenue by Region (2016-2021e) & (USD Million)
Table 19. Global Pneumococcal Vaccine Polyvalent Revenue by Region (2021-2026) & (USD Million)
Table 20. Global Pneumococcal Vaccine Polyvalent Sales by Type (2016-2021e) & (K Units)
Table 21. Global Pneumococcal Vaccine Polyvalent Sales by Type (2021-2026) & (K Units)
Table 22. Global Pneumococcal Vaccine Polyvalent Revenue by Type (2016-2021e) & (USD Million)
Table 23. Global Pneumococcal Vaccine Polyvalent Revenue by Type (2021-2026) & (USD Million)
Table 24. Global Pneumococcal Vaccine Polyvalent Price by Type (2016-2021e) & (USD/Unit)
Table 25. Global Pneumococcal Vaccine Polyvalent Price by Type (2021-2026) & (USD/Unit)
Table 26. Global Pneumococcal Vaccine Polyvalent Sales by Application (2016-2021e) & (K Units)
Table 27. Global Pneumococcal Vaccine Polyvalent Sales by Application (2021-2026) & (K Units)
Table 28. Global Pneumococcal Vaccine Polyvalent Revenue by Application (2016-2021e) & (USD Million)
Table 29. Global Pneumococcal Vaccine Polyvalent Revenue by Application (2021-2026) & (USD Million)
Table 30. Global Pneumococcal Vaccine Polyvalent Price by Application (2016-2021e) & (USD/Unit)
Table 31. Global Pneumococcal Vaccine Polyvalent Price by Application (2021-2026) & (USD/Unit)
Table 32. North America Pneumococcal Vaccine Polyvalent Sales by Country (2016-2021e) & (K Units)
Table 33. North America Pneumococcal Vaccine Polyvalent Sales by Country (2021-2026) & (K Units)
Table 34. North America Pneumococcal Vaccine Polyvalent Revenue by Country (2016-2021e) & (USD Million)
Table 35. North America Pneumococcal Vaccine Polyvalent Revenue by Country (2021-2026) & (USD Million)
Table 36. North America Pneumococcal Vaccine Polyvalent Sales by Type (2016-2021e) & (K Units)
Table 37. North America Pneumococcal Vaccine Polyvalent Sales by Type (2021-2026) & (K Units)
Table 38. North America Pneumococcal Vaccine Polyvalent Sales by Application (2016-2021e) & (K Units)
Table 39. North America Pneumococcal Vaccine Polyvalent Sales by Application (2021-2026) & (K Units)
Table 40. Europe Pneumococcal Vaccine Polyvalent Sales by Country (2016-2021e) & (K Units)
Table 41. Europe Pneumococcal Vaccine Polyvalent Sales by Country (2021-2026) & (K Units)
Table 42. Europe Pneumococcal Vaccine Polyvalent Revenue by Country (2016-2021e) & (USD Million)
Table 43. Europe Pneumococcal Vaccine Polyvalent Revenue by Country (2021-2026) & (USD Million)
Table 44. Europe Pneumococcal Vaccine Polyvalent Sales by Type (2016-2021e) & (K Units)
Table 45. Europe Pneumococcal Vaccine Polyvalent Sales by Type (2021-2026) & (K Units)
Table 46. Europe Pneumococcal Vaccine Polyvalent Sales by Application (2016-2021e) & (K Units)
Table 47. Europe Pneumococcal Vaccine Polyvalent Sales by Application (2021-2026) & (K Units)
Table 48. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales by Region (2016-2021e) & (K Units)
Table 49. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales by Region (2021-2026) & (K Units)
Table 50. Asia-Pacific Pneumococcal Vaccine Polyvalent Revenue by Region (2016-2021e) & (USD Million)
Table 51. Asia-Pacific Pneumococcal Vaccine Polyvalent Revenue by Region (2021-2026) & (USD Million)
Table 52. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales by Type (2016-2021e) & (K Units)
Table 53. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales by Type (2021-2026) & (K Units)
Table 54. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales by Application (2016-2021e) & (K Units)
Table 55. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales by Application (2021-2026) & (K Units)
Table 56. South America Pneumococcal Vaccine Polyvalent Sales by Country (2016-2021e) & (K Units)
Table 57. South America Pneumococcal Vaccine Polyvalent Sales by Country (2021-2026) & (K Units)
Table 58. South America Pneumococcal Vaccine Polyvalent Revenue by Country (2016-2021e) & (USD Million)
Table 59. South America Pneumococcal Vaccine Polyvalent Revenue by Country (2021-2026) & (USD Million)
Table 60. South America Pneumococcal Vaccine Polyvalent Sales by Type (2016-2021e) & (K Units)
Table 61. South America Pneumococcal Vaccine Polyvalent Sales by Type (2021-2026) & (K Units)
Table 62. South America Pneumococcal Vaccine Polyvalent Sales by Application (2016-2021e) & (K Units)
Table 63. South America Pneumococcal Vaccine Polyvalent Sales by Application (2021-2026) & (K Units)
Table 64. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales by Country (2016-2021e) & (K Units)
Table 65. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales by Country (2021-2026) & (K Units)
Table 66. Middle East & Africa Pneumococcal Vaccine Polyvalent Revenue by Country (2016-2021e) & (USD Million)
Table 67. Middle East & Africa Pneumococcal Vaccine Polyvalent Revenue by Country (2021-2026) & (USD Million)
Table 68. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales by Type (2016-2021e) & (K Units)
Table 69. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales by Type (2021-2026) & (K Units)
Table 70. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales by Application (2016-2021e) & (K Units)
Table 71. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales by Application (2021-2026) & (K Units)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Pneumococcal Vaccine Polyvalent Typical Distributors
Table 75. Pneumococcal Vaccine Polyvalent Typical Customers
List of Figures
Figure 1. Pneumococcal Vaccine Polyvalent Picture
Figure 2. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Type in 2020
Figure 3. Prevnar 13
Figure 4. Pneumovax23
Figure 5. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Application in 2020
Figure 6. 18 Years and Younger
Figure 7. 19 To 64 Years Old
Figure 8. 65 Years and Older
Figure 9. Global Pneumococcal Vaccine Polyvalent Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Pneumococcal Vaccine Polyvalent Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Pneumococcal Vaccine Polyvalent Sales (2016-2026) & (K Units)
Figure 31. Global Pneumococcal Vaccine Polyvalent Production Capacity (2016-2026) & (K Units)
Figure 32. Global Pneumococcal Vaccine Polyvalent Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Pneumococcal Vaccine Polyvalent Market Drivers
Figure 34. Pneumococcal Vaccine Polyvalent Market Restraints
Figure 35. Pneumococcal Vaccine Polyvalent Market Trends
Figure 36. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Manufacturer in 2020
Figure 37. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Manufacturer in 2020
Figure 38. Pneumococcal Vaccine Polyvalent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Pneumococcal Vaccine Polyvalent Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Pneumococcal Vaccine Polyvalent Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Region (2016-2026)
Figure 42. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Region (2016-2026)
Figure 43. North America Pneumococcal Vaccine Polyvalent Revenue (2016-2026) & (USD Million)
Figure 44. Europe Pneumococcal Vaccine Polyvalent Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Pneumococcal Vaccine Polyvalent Revenue (2016-2026) & (USD Million)
Figure 46. South America Pneumococcal Vaccine Polyvalent Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Pneumococcal Vaccine Polyvalent Revenue (2016-2026) & (USD Million)
Figure 48. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2016-2026)
Figure 49. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Type (2016-2026)
Figure 50. Global Pneumococcal Vaccine Polyvalent Price by Type (2016-2026) & (USD/Unit)
Figure 51. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2016-2026)
Figure 52. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Application (2016-2026)
Figure 53. Global Pneumococcal Vaccine Polyvalent Price by Application (2016-2026) & (USD/Unit)
Figure 54. North America Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2016-2026)
Figure 55. North America Pneumococcal Vaccine Polyvalent Revenue Market Share by Country (2016-2026)
Figure 56. North America Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2016-2026)
Figure 57. North America Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2016-2026)
Figure 58. Europe Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2016-2026)
Figure 59. Europe Pneumococcal Vaccine Polyvalent Revenue Market Share by Country (2016-2026)
Figure 60. Europe Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2016-2026)
Figure 61. Europe Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Pneumococcal Vaccine Polyvalent Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2016-2026)
Figure 66. South America Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2016-2026)
Figure 67. South America Pneumococcal Vaccine Polyvalent Revenue Market Share by Country (2016-2026)
Figure 68. South America Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2016-2026)
Figure 69. South America Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Pneumococcal Vaccine Polyvalent Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界の成人用ワクチン市場 2021：企業別、地域別、種類・用途別 The Adult Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rece…- 世界のワクチン受託製造市場 2021：企業別、地域別、種類・用途別 The Vaccine Contract Manufacturing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界のクロストリジウムワクチン市場 2021：企業別、地域別、種類・用途別 The Clostridium Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 世界のBCG結核（TB）ワクチン市場 2021：企業別、地域別、種類・用途別 The BCG Tuberculosis (TB) Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界のヒト用狂犬病ワクチン市場 2021：企業別、地域別、種類・用途別 The Rabies Vaccine for Humans market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…